Search Within

Alice Elizabeth Schluger

Formats
  1. Journal Article (9)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (15)
  2. GSK Faculty (13)
  3. Clinical Genetics Service (12)
  4. Population Sciences Research Program (12)
  5. Solid Tumor Oncology Division (12)
  6. Survivorship Research (12)

More Groups

People
  1. Kenneth Offit (12)
  2. Mark Robson (5)
  3. Charlene Schulz (4)
  4. Bayard Clarkson (3)
  5. Khedoudja Nafa (3)
  6. Larry Norton (3)

More People

Years
  1. 2010 (1)
  2. 2005 (1)
  3. 2002 (2)
  4. 1999 (1)
  5. 1997 (3)
  6. 1996 (3)

More Years

Publications
  1. American Journal of Human Genetics (4)
  2. Blood (2)
  3. Journal of Clinical Oncology (2)
  4. Breast Cancer Research and Treatment (1)
  5. Genetics in Medicine (1)
  6. JAMA - Journal of the American Medical Association (1)

More Publications

Publishers
  1. Cell Press (4)
  2. American Society of Clinical Oncology (2)
  3. American Society of Hematology (2)
  4. American Medical Association (1)
  5. BMJ Publishing Group Ltd. (1)
  6. Elsevier Inc. (1)

More Publishers

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline BRCA1 185delAG mutations in Jewish women with breast cancer
    Journal Article

    Offit, K.; Gilewski, T.; McGuire, P.; Schluger, A.; Hampel, H.; Brown, K.; Swensen, J.; Neuhausen, S.; Skolnick, M.; Norton, L.; more...
    Lancet (1996)

    Fulltext@MSK | Save
  • p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)
    Journal Article

    Louie, D. C.; Offit, K.; Jaslow, R.; Parsa, N. Z.; Murty, V. V. V. S.; Schluger, A.; Chaganti, R. S. K.
    Blood (1995)

    Fulltext@MSK | Save
  • A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia
    Journal Article

    Kolitz, J. E.; Kempin, S. J.; Schluger, A.; Wong, G. Y.; Berman, E.; Jhanwar, S.; Arlin, Z. A.; Gee, T.; Clarkson, B. D.
    Seminars in Oncology (1992)

    Fulltext@MSK | Save
  • Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
    Journal Article

    Berman, E.; Heller, G.; Santorsa, J. A.; McKenzie, S.; Gee, T.; Kempin, S.; Gulati, S.; Andreeff, M.; Kolitz, J.; Gabrilove, J.; more...
    Blood (1991)

    Fulltext@MSK | Save
  • Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas
    Journal Article

    Schneider, A. M.; Straus, D. J.; Schluger, A. E.; Lowenthal, D. A.; Koziner, B.; Lee, B. J.; Wong, G.; Clarkson, B. D.
    Journal of Clinical Oncology (1990)

    Fulltext@MSK | Save